Filing Details
- Accession Number:
- 0000884905-12-000079
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-16 16:28:55
- Reporting Period:
- 2012-11-15
- Filing Date:
- 2012-11-16
- Accepted Time:
- 2012-11-16 16:28:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884905 | Praxair Inc | PX | Industrial Inorganic Chemicals (2810) | 061249050 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1548282 | P Raymond Roberge | C/O Praxair, Inc. 39 Old Ridgebury Road Danbury CT 06810-5113 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-15 | 10,000 | $61.47 | 14,671 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-15 | 10,000 | $105.73 | 4,671 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2012-11-15 | 10,000 | $0.00 | 10,000 | $61.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,500 | 2008-02-27 | 2017-02-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 70 | Indirect | 401(k) |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $83.89 | 2009-02-26 | 2018-02-26 | 13,700 | 13,700 | Direct |
Common Stock | Stock Option (right to buy) | $60.92 | 2010-02-24 | 2019-02-24 | 27,090 | 27,090 | Direct |
Common Stock | Stock Option (right to buy) | $76.16 | 2011-02-23 | 2020-02-23 | 20,465 | 20,465 | Direct |
Common Stock | Stock Option (right to buy) | $97.84 | 2012-02-22 | 2021-02-22 | 19,790 | 19,790 | Direct |
Common Stock | Stock Option (right to buy) | $109.68 | 2013-02-28 | 2022-02-28 | 21,505 | 21,505 | Direct |
Common Stock | Deferred Stock | $0.00 | 15,346 | 15,346 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-02-26 | 13,700 | 13,700 | Direct |
2019-02-24 | 27,090 | 27,090 | Direct |
2020-02-23 | 20,465 | 20,465 | Direct |
2021-02-22 | 19,790 | 19,790 | Direct |
2022-02-28 | 21,505 | 21,505 | Direct |
15,346 | 15,346 | Direct |
Footnotes
- This total includes shares previously acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan and unvested restricted stock units.
- The $105.73 price reported is the weighted average sale price. The sale prices ranged from $105.56 to $105.99 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
- This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
- This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- Conversion to Praxair Common Stock is on a 1-for-1 basis.
- Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.